These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37061189)

  • 21. Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study.
    Kiburi SK; Mwangi J; Maina G
    Addict Sci Clin Pract; 2022 Dec; 17(1):71. PubMed ID: 36510246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in substance use stigma following a peer-recovery specialist behavioral activation intervention.
    Kleinman MB; Anvari MS; Felton JW; Bradley VD; Belcher AM; Abidogun TM; Hines AC; Dean D; Greenblatt AD; Wagner M; Earnshaw VA; Magidson JF
    Int J Drug Policy; 2024 Aug; 130():104511. PubMed ID: 39003894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients.
    Marshall K; Maina G; Sherstobitoff J
    Addict Sci Clin Pract; 2021 Jun; 16(1):42. PubMed ID: 34187549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff.
    Wu LT; Mannelli P; John WS; Anderson A; Schwartz RP
    Subst Abuse Treat Prev Policy; 2023 Sep; 18(1):55. PubMed ID: 37697326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 26. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
    Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
    Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland.
    Van Hout MC; Crowley D; McBride A; Delargy I
    BMC Fam Pract; 2018 Jun; 19(1):103. PubMed ID: 29960593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.
    Finlay AK; Morse E; Stimmel M; Taylor E; Timko C; Harris AHS; Smelson D; Yu M; Blue-Howells J; Binswanger IA
    J Gen Intern Med; 2020 Sep; 35(9):2529-2536. PubMed ID: 32583337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Counselor training and attitudes toward pharmacotherapies for opioid use disorder.
    Aletraris L; Edmond MB; Paino M; Fields D; Roman PM
    Subst Abus; 2016; 37(1):47-53. PubMed ID: 26168816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature.
    Bremer W; Plaisance K; Walker D; Bonn M; Love JS; Perrone J; Sarker A
    Front Public Health; 2023; 11():1141093. PubMed ID: 37151596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
    Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
    Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.
    Lister JJ; Weaver A; Ellis JD; Himle JA; Ledgerwood DM
    Am J Drug Alcohol Abuse; 2020 May; 46(3):273-288. PubMed ID: 31809217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.
    Russell C; Nafeh F; Pang M; MacDonald SF; Derkzen D; Rehm J; Fischer B
    BMC Public Health; 2022 Mar; 22(1):436. PubMed ID: 35246083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
    Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM
    J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
    Benville JR; Compton P; Giordano NA; Cheatle MD
    Drug Alcohol Depend; 2021 Apr; 221():108619. PubMed ID: 33667781
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.